Congenital infection by human cytomegalovirus (HCMV) is a major cause of birth defects and developmental abnormalities. Since guinea pig cytomegalovirus (GPCMV) crosses the placenta and causes infection in utero, GPCMV models are useful for studies of the mechanisms of transplacental transmission. During our characterization of a genomic locus required for GPCMV dissemination in animals, we found that the nucleotide sequence in and around the nearby immediate-early genes in our lineage of GPCMV strain 22122 [designated GPCMV (ATCC-P5)] showed clear differences from that reported previously for the same strain [designated GPCMV (UMN)] passaged extensively in vitro. Since in vitro passaging of HCMV is known to result in genetic alterations, especially in the UL128-UL131A locus, and loss of growth ability in particular cell types, in this study we determined the complete genome sequence of GPCMV (ATCC-P5), which grows efficiently in animals. A total of 359 differences were identified between the genome sequences of GPCMV (UMN) and GPCMV (ATCC-P5), and these resulted in structural differences in 29 protein-encoding regions. In addition, some genes predicted from our analysis but not from GPCMV (UMN) are well conserved among cytomegaloviruses. An additional 18 passages of GPCMV (ATCC-P5) in vitro generated no further marked alterations in these genes or in the locus corresponding to the HCMV UL128-UL131A. Our analyses indicate that the published sequence of GPCMV (UMN) contains a substantial number of sequencing errors and, possibly, some mutations resulting from a long history of passaging in vitro. Our re-evaluation of the genetic content of GPCMV will provide a solid foundation for future studies.
INTRODUCTION
Human cytomegalovirus (HCMV, species Human herpesvirus 5) is the most common cause of congenital virus infection. Congenital HCMV infection occurs in 0.2-1 % of all births, and causes birth defects and developmental abnormalities, including sensorineural hearing loss (SNHL) and developmental delay (Koyano et al., 2009; Ogawa et al., 2007; Pass, 2001 ). Animal models are often valuable for understanding pathogenesis as well as for developing therapeutics for infectious diseases. In contrast to murine CMV (MCMV, Murid herpesvirus 1) and rat CMV (RCMV, Murid herpesvirus 2), guinea pig CMV (GPCMV, Caviid herpesvirus 2) crosses the placenta and causes infection in utero. This makes GPCMV animal models useful for studies on the mechanisms of transplacental transmission of CMV as well as for evaluation of vaccines, antiviral drugs and passive antibody to prevent congenital CMV diseases (reviewed by Kern, 2006; Schleiss, 2006) . We demonstrated congenital CMV-associated labyrinthitis in a guinea pig model in which vertical infection by GPCMV occurred through the placenta (Katano et al., 2007) .
Indeed, previously we reported that the GPCMV (22122 strain) stock purchased from the ATCC is a mixture of two variants of the 22122 strain, one containing and the other lacking a 1.6 kb locus (GPCMV/full and GPCMV/del, respectively; Nozawa et al., 2008) . Importantly, the 1.6 kb locus encodes orthologues of HCMV UL128 and UL130 and was required for efficient viral growth in animals but not in cell culture (Yamada et al., 2009) . HCMV UL128, UL130 and UL131A are essential for infection of endothelial and epithelial cells, and also for viral transmission to leukocytes (Hahn et al., 2004; Ryckman et al., 2008; Wang & Shenk, 2005a) . These genes encode glycoproteins that form a complex with glycoproteins H (gH) and L (gL) (Ryckman et al., 2008) and localize in virion particles (Wang & Shenk, 2005a, b) .
Recently, M. Schleiss at the University of Minnesota (UMN) and his collaborators reported the genome sequence of GPCMV strain 22122, which is referred to hereafter as GPCMV (UMN) (Schleiss et al., 2008) . However, during the analyses of the GPCMV orthologues of UL128 and UL130, we recognized several critical differences in the nucleotide sequence around these genes, including the immediate-early genes, between GPCMV (UMN) and our sequence (Yamada et al., 2009) . In the cases of HCMV and rhesus CMV (RhCMV, Macacine herpesvirus 3), long passages of virus isolates in fibroblast cells result in genetic alterations, including ORF-disrupting mutations and deletions, that abolish growth ability in epithelial and endothelial cells (Cha et al., 1996; Dargan et al., 2010; Dolan et al., 2004; Lilja & Shenk, 2008; Murphy et al., 2003; Rivailler et al., 2006) . The main part of the GPCMV (UMN) sequence was determined based on a bacterial artificial chromosome (BAC) clone derived from a GPCMV stock that was prepared after long in vitro passages and seems unable to grow efficiently in animals, at least in part owing to its lack of the 1.6 kb locus (Schleiss et al., 2008) . Therefore, in this study we determined the GPCMV sequence in virus stocks in which in vivo growth ability was verified; we identified significant differences between the sequences of our stocks and GPCMV (UMN).
RESULTS

GPCMV sequence of low-passage virus
To analyse the GPCMV genome sequence, we prepared plasmid libraries from a virus stock, GPCMV (ATCC-P5), which had been passaged in guinea pig fibroblast cells five times after we purchased it from the ATCC. The product sheet attached to the ATCC stock described its passage history as follows: 44 passages in guinea pig, three passages in tissue culture of guinea pig embryo and one passage in guinea pig lung fibroblasts (GPL). Although GPCMV (ATCC-P5) as well as the original stock purchased from ATCC are a mixture of two variants, one containing and the other lacking the HCMV UL128 and UL130 orthologues, the former variant grew efficiently in guinea pigs (Nozawa et al., 2008; Yamada et al., 2009) . Because this project was initiated before publication of the GPCMV (UMN) sequence (Schleiss et al., 2008) , sequences of plasmid-cloned GPCMV segments were determined by using flanking primers located in the multiple cloning sites of the plasmid and then by using a primer-walking strategy. The GPCMV (ATCC-P5) sequence was 233 525 bp in length. Comparison of the GPCMV (ATCC-P5) sequence with the GPCMV (UMN) sequence identified 359 nucleotide sequence differences scattered across the entire genome (Supplementary Table S1 , available in JGV Online). Regions spanning positions 29279-58370, 74849-107811, and 176487-197209 and the terminal repeat (TR) contain more differences than other regions. The GPCMV (UMN) sequence has 147 single nucleotide alterations, 177 insertions and 35 deletions as compared with the GPCMV (ATCC-P5) sequence.
GPCMV (ATCC-P5) sequence was conserved in another virus stock prepared from an infected animal
Since the strains analysed at UMN and in this study can be traced to the same virus distributed by ATCC, the differences between GPCMV (UMN) and GPCMV (ATCC-P5) may be the result of adaptations of the virus to in vitro cell-culture conditions, random alterations because of the lack of selection pressure in vitro and/or technical errors in sequencing. To understand how these differences emerged, we next analysed the sequence of another virus stock, GPCMV (SG-P3), that was derived from the salivary glands of a GPCMV (ATCC-P5)-infected guinea pig and had been amplified by three passages in vitro. After intraperitoneal inoculation, efficient dissemination of GPCMV (SG-P3) to spleen, liver, lung and finally to salivary gland in the animals was demonstrated by real-time PCR detection of viral DNA as well as by immunohistochemical detection of viral antigens (data not shown). By direct sequencing of PCR products of GPCMV (SG-P3) DNA, the regions covering 334 of the 359 differences between GPCMV (UMN) and GPCMV (ATCC-P5) were determined (Supplementary Table S1 ). Twenty-five sites of the 359 differences were not determined successfully, since PCR amplification of fragments in the TR and replication origin regions, which contain many repetitive sequences, was technically difficult. The GPCMV (SG-P3) sequences at and around the remaining 334 sites were identical to the GPCMV (ATCC-P5) sequence, indicating that the sequence of a virus stock prepared after five passages from the original ATCC stock was identical to that of a virus stock prepared after passage through an animal and then three additional passages in cell culture.
Differences in coding content of GPCMV (ATCC-P5) and GPCMV (UMN)
Next, we analysed the effect of the sequence differences on coding content. The numbering of ORFs, except for GP123, is based on the previous reports by Schleiss et al. (2008) and Nozawa et al. (2008) , i.e. numbering from the left to right of the genome, with consideration of HCMV homologue designations. In this study, we use a 'GP' prefix to indicate ORFs that have homologues with .50 % similarity in more than two of seven other CMVs, including MCMV, RCMV, RhCMV, tupaia herpevirus 1 (THV1, Tupaiid herpesvirus 1), simian CMV (Cercopithecine herpesvirus 5), chimpanzee CMV (CCMV, Panine herpesvirus 2) and HCMV; a 'gp' prefix is used for the remaining ORFs. Of the 105 protein-encoding ORFs predicted from the GPCMV (UMN) sequence, 47 contain at least one nucleotide difference in GPCMV (ATCC-P5); this resulted in structural changes, including emergence or loss of ORFs, reduction or extension of ORF sizes and local frameshifts in 29 ORFs (Table 1, Fig. 1 ). Details of the structural changes in the ORFs other than those in the six
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ORFs characterized previously (Yamada et al., 2009 ) are as follows. New stop codons abolish four GPCMV (UMN) ORFs: gp6, gp7, gp105.1 and GP121. A frameshift due to a nucleotide insertion merges gp28.2 with GP29. A mutation in the start codon disables gp57.2. A 1 bp insertion eliminates the gp24.1 ORF, and leads to a longer GP25 ORF in GPCMV (ATCC-P5). The GPCMV (ATCC-P5) GP25 ORF has a longer region of homology with its orthologues in other CMVs (Table 2 ). In addition to these, frameshifts due to nucleotide deletion(s) or insertion(s) resulted in the extension of 16 ORFs and the truncation of five ORFs. Updated guinea pig CMV sequence GP112 exon 1, predicted by Schleiss et al. (2008) , might be considered to be an independent ORF (it has start and stop codons); the ORF is extended in the GPCMV (ATCC-P5) sequence because of a sequence difference in the UMNpredicted stop codon. Since the adjacent predicted exon (GP112 exon 2) might also be considered to be an independent ORF, it can be GP113. A missing nucleotide in the GPCMV (UMN) GP113 sequence led to an overlong coding sequence. Since the corresponding loci in HCMV and MCMV have complex exonic structures, as shown in Fig. 2 (a) (Bühler et al., 1990; Wright & Spector, 1989; Ciocco-Schmitt et al., 2002) , 39-and 59-RACE reactions were performed to determine the structure of mature transcripts in the GP112-113 locus. The RACE reaction using primer P1 and also that using primer P2 indicated the transcript B shown in Fig. 2 (b), which consists of three exons, as being a dominant product. The amino acid sequence of this GP112-113 transcript B is similar to those of HCMV UL112-113 p43 and MCMV M112-113 36 kDa in the vicinity of splice junctions (Fig. 2c ). The presence of transcript D shown in Fig. 2 (b) was suggested by the generation of a PCR product from oligo-dT-primed cDNAs with a combination of P3 and P4 primers, although the combination of P3 (or P1) and P5 primers (or other downstream primers) predominantly generated a product derived from transcript B. It was technically hard to prove the presence of transcript A, since there was a trace amount of viral DNA in the RNA preparations. Thus, our experiments detected transcript B as a major product and transcript D as a minor product, but could not detect transcripts A or C. This might be because of differences in expression kinetics and/or owing to the relative amounts of the transcripts, as shown previously for the M112-113 and UL112-113 transcripts (Bühler et al., 1990; Wright & Spector, 1989; Ciocco-Schmitt et al., 2002) . We speculate upon the presence of transcript C based on the following facts: (i) the amino acid sequence in the vicinity of the splice junctions of the second and third exons of the GP112-113 transcript C is similar to that of M112-113 36 kDa, and (ii) the length of coding region in the third exon of the GP112-113 transcript C (375 aa) is similar to those of HCMV UL112-113 p50 (424 aa) and MCMV M112-113 38 kDa (347 aa).
Significant alterations in amino acid sequences were also observed in several genes conserved among all herpesviruses. For example, combinations of local frameshifts in the GP86, GP94 and GP114 genes do not change the overall lengths of the encoded proteins markedly, but do cause alterations in the amino acid sequences, which result in poor sequence alignment of the GPCMV (UMN) products with other CMVs' orthologues ( Fig. 3) .
We have newly identified GP48A as being a homologue of HCMV UL48A (Lai & Britt, 2003) , CCMV UL48A (Davison et al., 2003) , RhCMV rhUL48a (Rivailler et al., 2006) , MCMV m48.2 (Brocchieri et al., 2005; Cheng et al., 2010) and human herpesvirus 6B (HHV-6B) U32 (Dominguez et al., 1999) , all of which encode the small capsid protein, although the GPCMV (UMN) and GPCMV (ATCC-5) sequences are identical in this region. Similarly gp80.5, a homologue of HCMV UL80.5 that encodes the precursor assembly protein (Wood et al., 1997; Yu et al., 2005) was identified.
Long in vitro passages may not explain the differences between GPCMV (UMN) and GPCMV (ATCC-P5)
It is possible that at least some of the differences between GPCMV (UMN) and GPCMV (ATCC-P5) arose during lengthy in vitro passage of GPCMV (UMN). To see whether extended in vitro passage can result in alterations similar to those found in the GPCMV (UMN) sequence, we determined the sequences of the GP86, GP94 and GP114 genes from a virus stock GPCMV (SG-P21) that was passaged 18 times as cell-free virus, starting from GPCMV (SG-P3), over the course of 90 days. Since the sequences of those genes were identical between GPCMV (SG-P3) and GPCMV (SG-P21) (Fig. 3a) , extended passage in vitro cannot explain all of the differences.
To see whether the differences can be ascribed to sequencing of a particular GPCMV-BAC clone, we sequenced some regions of pN13R10, one of the GPCMV BAC clones developed by Schleiss, McVoy and their colleagues (Cui et al., 2008) . We found that the regions of pN13R10 we analysed [in total a 46 kb region that covered 221 of the 359 differences between GPCMV (UMN) and GPCMV (ATCC-P5); Supplementary Table S1 ] have identical sequences to those of GPCMV (ATCC-P5), except for two alterations: one we previously described in the GP129 gene (Yamada et al., 2009 ) and the other in the intergenic region between GP129 and GP131. Although the materials that the UMN group used for their sequencing were not explicitly described ORFs predicted from the GPCMV (ATCC-P5) sequence are shown as speckled arrows and white arrows with a black outline. Grey arrows and white arrows with a grey outline indicate the ORFs identified and/or characterized experimentally in this and our previous studies (Nozawa et al., 2008; Yamada et al., 2009) . ORFs that were predicted from the GPCMV (UMN) sequence and that are structurally different from those of GPCMV (ATCC-P5) are indicated by black arrows. Numbers with grey backgrounds indicate PRFs absent from GPCMV (ATCC-P5). Speckled and grey arrows indicate ORFs with a 'GP' prefix, i.e. those having homologues with .50 % similarity in more than two other CMVs. White arrows with black or grey outlines indicate ORFs with a 'gp' prefix, i.e. those outside the above-mentioned criteria. Splicing patterns confirmed experimentally in this and in our previous studies are shown by thin lines. An asterisk at GP128 indicates that this ORF was annotated improperly as GP123 in the GPCMV (UMN) sequence.
Updated guinea pig CMV sequence in their publication, at least one of the GPCMV-BAC clones they developed has a sequence more similar to the GPCMV (ATCC-P5) sequence than to the GPCMV (UNM) sequence.
The GP129-131 region is stable during in vitro passages
Since it is well known that alterations, including deletions, frameshifts due to insertions and deletions of DNA segments and substitutions that disrupt protein functions, in the HCMV UL128-131A locus appear relatively soon after passages of clinical isolates in cell culture , the stability of the equivalent locus in GPCMV was analysed by comparing sequences between GPCMV(SG-P3) and GPCMV(SG-P21). The equivalent locus encodes GP129 and GP131, homologues of HCMV UL128 and UL130, respectively, but not HCMV UL131A. GP128 encodes an MCMV ie3 homologue and gp130 is an uncharacterized ORF with an orientation opposite to that of GP129 and GP131 ( Fig. 1 ; Yamada et al., 2009) . We previously showed that GPCMV variants lacking this locus yielded 1.25-fold more infectious progeny virus than GPCMV variants containing this locus did in each passage, and that there was no evidence for the emergence of a virus subpopulation containing a small deletion in the GP129-131 region after long in vitro passages (Nozawa et al., 2008) . However, our earlier study did not examine whether passaging GPCMV in vitro resulted in local frameshifts or substitutions that may disrupt protein functions encoded in the region. To address this, 2 kb fragments obtained from both virus stocks were amplified by PCR and cloned into a plasmid vector. In agreement with our earlier results, no deletion mutations were present in the GP129-131 region of 34 clones from GPCMV (SG-P3) or 35 clones from GPCMV (SG-P21). Although 14 SG-P3-derived clones and 14 SG-P21-derived clones had nucleotide alterations in the region, there were no stop codons or prevalent mutations that may interrupt the function(s) of GP129 and/or GP131 ORFs (not shown), suggesting that the GPCMV GP129-131 region is more stable than the HCMV UL128-131A region during passaging in fibroblast cells.
DISCUSSION
In this study, we determined the complete genome sequence of a GPCMV stock, GPCMV (ATCC-P5), that grew efficiently in animals, and found many differences relative to the GPCMV (UMN) sequence, although GPCMV (ATCC-P5) and GPCMV (UMN) stocks were originally derived from same strain, GPCMV 22122.
Our analyses suggest that most, if not all, of the differences between the GPCMV (ATCC-P5) and GPCMV (UMN) sequences represent artefacts or errors in the GPCMV (UMN) sequence, since (i) some genes of GPCMV (UMN) are not well conserved relative to CMVs of other species, (ii) one of the GPCMV-BACs that were derived from GPCMV (UMN) had a sequence almost identical to the GPCMV (ATCC-P5) sequence, and (iii) further amplification of GPCMV (SG-P3) in cell culture for .90 days did not lead to the emergence of any dominant alterations. Although it seems unlikely, the long in vitro passage history of GPCMV (UMN) may have allowed accumulation of some of the sequence differences.
Effects of in vitro passaging on MCMV genome sequences were examined previously by independent in vitro passaging of three sister clones of MCMV for 21 days followed by determination of the resulting genome-wide sequence changes (Cheng et al., 2010) . Alterations in just two base pairs were found in one of the three MCMV clones, indicating that the mutation rate for MCMV during in vitro passage is~1.4610 27 bp 21 day
21
. Thus, the MCMV genome is highly stable during multiple rounds of in vitro passages. In the case of HCMV, genetic polymorphism can be found in a subset of genes, especially in those encoding membrane-associated or secreted proteins . The sequences in each polymorphic allele are stable in patients Stanton et al., 2005) and during cell culture (Lurain et al., 2006) . Although recombination may occur between two strains with different sequences in polymorphic alleles during a long evolution process, these alleles are not currently under selection (Yan et al., 2008; Mattick et al., 2004) . Evidence for recombination is also provided in the instance of multiple strain infections commonly observed in immunodeficient populations (Bates et al., 2008) . These observations suggest that hypervariation in particular genes is a result of long-term allelic selection during passage through humans (Bradley et al., 2008; Dolan et al., 2004) . HCMV RL13 and UL128-UL131A are exceptions, since they often mutate during the early stage of adaptation of HCMV to cell culture Dolan et al., 2004; Hahn et al., 2004; Dargan et al., 2010; Stanton et al., 2010) . For example, a mutation in the HCMV UL128-131A locus became detectable (.10 % of the population) after 15-20 passages and then became dominant within a few passages . In contrast to the HCMV UL128-UL131A locus, the GPCMV GP129-131 locus had a limited number of alterations during amplification in vitro, and the observed frequency of alterations was not more than the frequency of error reading of PCR enzymes. Thus, the GPCMV sequence is probably as stable as other CMVs. However, we should admit that passages for 90 days may not be long enough to accumulate some changes, as evidenced by highthroughput sequence analyses of the extensive passage history of lab strain AD169 of HCMV (Bradley et al., 2009) . In spite of the relatively stable nature of the GPCMV sequence, Cui et al. (2008) and we (N. Inoue and S. Yamada, unpublished data) observed that generation of GPCMV-BAC in cells by homologous recombination resulted in large deletions not only around the site of insertion but also at remote sites. Cui et al. suggested that selection against propagation of viruses with over-length genomes probably occurred at the time of viral DNA packaging, as there is probably a limit to the length of DNA that can be packaged efficiently into viral capsids. Although it seems unlikely, to escape from such a selection many single-base insertions/deletions/substitutions that reduce viral growth speed might be introduced during generation of BAC clone(s) used for sequencing of GPCMV (UMN).
In conclusion, we robustly determined the genome sequences of GPCMV lineages that can grow well in vivo.
In addition, we re-evaluated the GPCMV coding content and found that the virus genome is stable during in vitro culture. Our study will provide a solid foundation for studies using GPCMV animal models.
METHODS
Virus strains and cell lines. The original stock of GPCMV (22122 strain) was purchased from the ATCC (VR-682). This stock was inoculated onto guinea pig lung fibroblasts (GPL; ATCC CCL-158) and cultured in F-12 medium supplemented with 10 % FBS for 5-6 days, as described by Nozawa et al. (2008) . The infected cells (ATCC-P1) were propagated by co-culturing with uninfected GPL cells at a ratio of 1 : 5-1 : 10 four times to prepare a large stock of cellfree GPCMV (ATCC-P5). GPCMV stocks were also prepared from salivary glands (SG) of a guinea pig (Hartley strain) infected with the GPCMV (ATCC-P5) stock. SG were minced, sonicated briefly, and centrifuged to remove debris. These supernatants were used for infection of GPL cells, and viral stocks were prepared after propagation of the cell-free virus three times (SG-P3) or 21 times (SG-P21) in GPL cells. GPCMV can be reliably recovered from SG of guinea pigs at 3 weeks after intraperitoneal inoculation with GPCMV (ATCC-P5) or GPCMV (SG-P3).
Sequencing of GPCMV (ATCC-P5). Construction of plasmid libraries spanning the GPCMV (ATCC-P5) genome was described previously (Nozawa et al., 2008) . After mapping the plasmids by Southern blotting and by sequencing of the ends of inserts, the complete GPCMV genome sequence was determined by a primerwalking strategy. Episomal GPCMV DNA prepared by the method of Hirt (1967) was used to determine the terminal regions. A commercial kit (BigDye Terminator Cycle Sequencing kit version 3.1; PE Applied Biosystems) was used for sequencing reactions, and the reactions were analysed in an ABI Prism 7500 sequence detection system (PE Applied Biosystems). Data were assembled and analysed by using the programs ATGC and GENETYX (Genetyx). The nucleotide sequence determined in this study has been submitted to the DNA Data Bank of Japan (DDBJ) (accession no. AB592928). The GPCMV (UMN) sequence (accession no. FJ355434.1, as of 24 August 2010) was used for comparison.
Sequencing of GPCMV (SG-P3), (SG-P21) and a GPCMV-BAC clone pN13R10. Viral DNA samples for direct sequencing were prepared as described previously by Igarashi et al. (1993) . Briefly, GPCMV-infected GPL cells were suspended in a buffer containing 0.1 % Nonidet P-40 and incubated for 10 min on ice before nuclei were removed by centrifugation at 1200 g for 5 min. The supernatant fluid was extracted with phenol/chloroform, and viral DNA was recovered by ethanol precipitation. Purified viral DNA obtained from GPCMV (SG-P3) and GPCMV (SG-P21) were used as template for PCR using primer pairs specific to the genome regions containing the differences in sequence between GPCMV (UMN) and GPCMV (ATCC-P5). PCR products were 
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extracted from agarose gels after electrophoresis (Wizard SV Gel and PCR Clean-Up system; Promega) and used for sequencing reactions.
Viral DNA prepared from cell-free virus stocks were also used to obtain plasmid clones containing the GP129-131 region. Culture supernatants were incubated in a buffer containing 10 mM Tris/HCl (pH 8.0), 150 mM NaCl, 10 mM EDTA, 1 mg proteinase K ml 21 and 0.1 % SDS at 55 uC for 3 h, extracted with phenol/chloroform, and then viral DNA was recovered by ethanol precipitation. Fiftymicrolitres of PCR mixture containing 16 Expand High Fidelity PLUS Reaction Buffer with MgCl 2 , 200 mM dNTPs, 0.5 mM primers (59-GTAGGTACCCGCAGGTTTGC-39 and 59-TTGATCACGGAC-GACGATAC-39), 0.5 U of Expand High Fidelity PLUS Enzyme Blend (Expand High Fidelity PLUS PCR System; Roche Applied Science) and 100 ng of the template DNA. Thermal cycling conditions were denaturation for 5 min and 15 cycles of: 98 uC for 45 s, 63 uC for 45 s and 72 uC for 5 min. After phenol/chloroform extraction, PCR products were purified on a S-400HR column (GE Healthcare) and ligated into pGEM-T easy (Promega). Plasmid DNA from .30 transformants was sequenced as described above.
Analysis of genetic content. To identify ORFs in the GPCMV sequences, GeneMark.hmm 2.0 Eukaryotic Virus Version (http:// exon.biology.gatech.edu/eukhmm.cgi) was used with default parameters (Besemer et al., 2001) . Database searches for homologous amino acid sequences were done using BLASTP (National Center for Biotechnology Information, NIH, USA; BLAST; http://blast.ncbi.nlm. nih.gov/Blast.cgi) with default parameters against the non-redundant combined nucleotide sequence database, and TFASTAX (University of Virginia, Charlottesville, VA, USA; http://fasta.bioch.virginia.edu/ fasta_www2/fasta_list2.shtml) with default parameters against the GB171.0 viral database. Outcomes with E values ,0.1 were defined as a homologue. To compare the sequences of the gene products conserved among all herpesviruses, amino acid sequences were aligned by CLUSTAL W (DDBJ; http://clustalw.ddbj.nig.ac.jp/top-e. html), and the alignment table was transferred to an editable format by using MEGA version 4.1 (Beta) (http://www.megasoftware.net/). The following sequences were used for comparison: human (GenBank accession no. NC_006273), chimpanzee (NC_003521.1), rhesus (NC_006150.1), tupaia (tree shrew; NC_002794.1), rat (AF232689.2) and murine (NC_004065.1) CMVs.
RACE. Total RNA samples were prepared from GPCMV-infected GPL cells by using an RNeasy Plus Mini kit (Qiagen), and cDNAs were synthesized by reverse transcriptase (Primescript Reverse Transcriptase; Takara). RACE reactions were done using a commercial kit (SMART RACE cDNA Amplification kit; Clontech) with primers specific to the predicted GP112-113 exon 1 (P1: 59-GAGATCCCCGGATATCGGCAAAACA-39 for 39-RACE and P2: 59-GGCCTGTCTCCTGCGCTCTTTCTGT-39 for 59-RACE) as described in the manufacturer's instructions. Similarly, cDNAs were synthesized using oligo dT (New England Biolabs) and used for PCR with different combinations of primers. The primers include P3 (59-CCGGATATCGGCAAAACAGA-39), P4 (59-GTCCCTCCCGAA-TCCCGTTA-39) and P5 (59-CGTCTCACCGCCTCTAGACTG-39). Sequences of the amplified products were determined as described above.
